Beta 1-adrenergic antagonists and melatonin rese... [J Med Genet. 2003] - PubMed

Save items

loading

Related citations in PubMed

beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. [J Med Genet. 2001]
beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.
De Leersnyder H, de Blois MC, Vekemans M, Sidi D, Villain E, Kindermans C, Munnich A. J Med Genet. 2001 Sep; 38(9):586-90.
[Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome]. [Rev Neurol (Paris). 2003]
[Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome].
De Leersnyder H, de Blois MC, Bresson JL, Sidi D, Claustrat B, Munnich A. Rev Neurol (Paris). 2003 Nov; 159(11 Suppl):6S21-6.
Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. [J Pediatr. 2006]
Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin.
Carpizo R, Martínez A, Mediavilla D, González M, Abad A, Sánchez-Barceló EJ. J Pediatr. 2006 Sep; 149(3):409-11.
Review Role of melatonin in the regulation of human circadian rhythms and sleep. [J Neuroendocrinol. 2003]
Review Role of melatonin in the regulation of human circadian rhythms and sleep.
Cajochen C, Kräuchi K, Wirz-Justice A. J Neuroendocrinol. 2003 Apr; 15(4):432-7.
Review Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment. [Trends Endocrinol Metab. 2006]
Review Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment.
De Leersnyder H. Trends Endocrinol Metab. 2006 Sep; 17(7):291-8. Epub 2006 Aug 4.

See reviews... See all...

Cited by 9 PubMed Central articles

Clinical uses of melatonin in pediatrics. [Int J Pediatr. 2011]
Clinical uses of melatonin in pediatrics.
Sánchez-Barceló EJ, Mediavilla MD, Reiter RJ. Int J Pediatr. 2011; 2011:892624. Epub 2011 Jun 16.
Pharmacological treatment of disruptive behavior in Smith-Magenis syndrome. [Am J Med Genet C Semin Med Gen...]
Pharmacological treatment of disruptive behavior in Smith-Magenis syndrome.
Laje G, Bernert R, Morse R, Pao M, Smith AC. Am J Med Genet C Semin Med Genet. 2010 Nov 15; 154C(4):463-8.
Autism spectrum features in Smith-Magenis syndrome. [Am J Med Genet C Semin Med Gen...]
Autism spectrum features in Smith-Magenis syndrome.
Laje G, Morse R, Richter W, Ball J, Pao M, Smith AC. Am J Med Genet C Semin Med Genet. 2010 Nov 15; 154C(4):456-62.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in...
Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.
J Med Genet. 2003 Jan ;40(1):74-8.

PubMed
Beckwith-Wiedemann syndrome and assisted reproduction technology (ART).
Beckwith-Wiedemann syndrome and assisted reproduction technology (ART).
J Med Genet. 2003 Jan ;40(1):62-4.

PubMed
Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis ...
Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO.
J Biol Chem. 2003 Mar 21 ;278(12):10055-60. Epub 2003 Jan 13 .

PubMed
Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease per...
Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective.
Clin Microbiol Rev. 2003 Jan ;16(1):144-72.

PubMed
Leaching of glycosaminoglycans from tissues by the fixatives formalin-saline and...
Leaching of glycosaminoglycans from tissues by the fixatives formalin-saline and formalin-cetrimide.
Histochem J. 1975 Jul ;7(4):361-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 9 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information